Robert Horsburgh
Profiles

Charles R Horsburgh, Jr, MD

Professor, Global Health - Boston University School of Public Health

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Other Positions

  • Professor, Epidemiology - Boston University School of Public Health
  • Professor, Biostatistics - Boston University School of Public Health
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • - Boston Medical Center

Education

  • Case Western Reserve University, MD Field of Study: Medicine
  • Yale University, MS Field of Study: Urban Studies
  • Princeton University, AB Field of Study: Architecture

Classes Taught

  • SPHEP730
  • SPHEP764
  • SPHEP784
  • SPHEP911
  • SPHGH941

Publications

  • Published on 8/28/2024

    Campbell JI, Lavache D, Garing A, Sabharwal V, Haberer JE, Dubois M, Jenkins HE, Brooks MB, Joseph NT, Kissler K, Horsburgh CR, Jacobson KR. Evaluation of the Tuberculosis Infection Care Cascade Among Pregnant Individuals in a Low-Tuberculosis-Burden Setting. Open Forum Infect Dis. 2024 Sep; 11(9):ofae494. PMID: 39238842.

    Read At: PubMed
  • Published on 8/1/2024

    Wijk M, Gausi K, Malatesta S, Weber SE, Court R, Myers B, Carney T, Parry CDH, Horsburgh CR, White LF, Wiesner L, Warren RM, Uren C, McIlleron H, Kloprogge F, Denti P, Jacobson KR. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. J Antimicrob Chemother. 2024 Aug 01; 79(8):2022-2030. PMID: 38985541.

    Read At: PubMed
  • Published on 8/1/2024

    Cirillo D, Anthony R, Gagneux S, Horsburgh CR, Hasan R, Darboe S, Laniado-Laborin R, Probandari A, Tukvadze N, Arcêncio RA, Bimba JS, Brighenti S, Chesov D, Chiang CY, Kalmambetova G, Knight G, Konstantynovska O, Kruse A, Lange C, Mayanja-Kizza H, McBryde E, Min J, Sanchez-Montalva A, Sulis G, Tsogt B, Van Der Walt M, Yeboah-Manu D, Hauser J. A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis. Lancet Glob Health. 2024 Aug; 12(8):e1225-e1226. PMID: 39030054.

    Read At: PubMed
  • Published on 8/1/2024

    Menzies NA, Swartwood NA, Cohen T, Marks SM, Maloney SA, Chappelle C, Miller JW, Beeler Asay GR, Date AA, Horsburgh CR, Salomon JA. The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study. Lancet Public Health. 2024 Aug; 9(8):e573-e582. PMID: 39095134.

    Read At: PubMed
  • Published on 8/1/2024

    Regan M, Barham T, Li Y, Swartwood NA, Beeler Asay GR, Cohen T, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Winston CA, Menzies NA. Risk factors underlying racial and ethnic disparities in tuberculosis diagnosis and treatment outcomes, 2011-19: a multiple mediation analysis of national surveillance data. Lancet Public Health. 2024 Aug; 9(8):e564-e572. PMID: 39095133.

    Read At: PubMed
  • Published on 7/25/2024

    Burman W, Rucsineanu O, Horsburgh CR, Johnston J, Dorman SE, Menzies D. Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach. PLoS Med. 2024 Jul; 21(7):e1004438. PMID: 39052666.

    Read At: PubMed
  • Published on 7/1/2024

    Vasquez A, Mitnick C, Nyaruhirira AU, Chiang CY, Horsburgh CR. A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB. IJTLD Open. 2024 Jul; 1(7):329-331. PMID: 39035429.

    Read At: PubMed
  • Published on 6/1/2024

    Shapiro AN, Dolynska M, Chiang SS, Rybak N, Petrenko V, Horsburgh CR, Kobe J, Terleieva I, Sakalska O, Jenkins HE. The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020. IJTLD Open. 2024 Jun; 1(6):258-265. PMID: 39021447.

    Read At: PubMed
  • Published on 5/8/2024

    Martinez L, Seddon JA, Horsburgh CR, Lange C, Mandalakas AM. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respir Med. 2024 Aug; 12(8):633-641. PMID: 38734022.

    Read At: PubMed
  • Published on 4/23/2024

    Sinha P, Ezhumalai K, Du X, Ponnuraja C, Dauphinais MR, Gupte N, Sarkar S, Gupta A, Gaikwad S, Thangakunam B, Paradkar M, Christopher DJ, Mave V, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Padmapriyadarsini C, Gupte A. Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis. Clin Infect Dis. 2024 Apr 23. PMID: 38652286.

    Read At: PubMed

News & In the Media